Financhill
Back

Summit Therapeutics Stock Price Chart

  • The current trend is moderately bearish and SMMT is experiencing slight selling pressure.

Summit Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 25.23 Sell
20-day SMA: 25.86 Sell
50-day SMA: 21.95 Buy
200-day SMA: 19.19 Buy
8-day EMA: 25.04 Sell
20-day EMA: 24.73 Sell
50-day EMA: 22.97 Buy
200-day EMA: 18.44 Buy

Summit Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.83 Buy
Relative Strength Index (14 RSI): 49.42 Sell
Chaikin Money Flow: -1165503 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (19.85 - 28.69) Sell
Bollinger Bands (100): (17.57 - 24.19) Buy

Summit Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Summit Therapeutics Stock

Is Summit Therapeutics Stock a Buy?

SMMT Technical Analysis vs Fundamental Analysis

Buy
54
Summit Therapeutics (SMMT) is a Buy

Is Summit Therapeutics a Buy or a Sell?

Summit Therapeutics Stock Info

Market Cap:
17.8B
Price in USD:
23.96
Share Volume:
2.5M

Summit Therapeutics 52-Week Range

52-Week High:
36.91
52-Week Low:
2.10
Buy
54
Summit Therapeutics (SMMT) is a Buy

Summit Therapeutics Share Price Forecast

Is Summit Therapeutics Stock a Buy?

  • Summit Therapeutics share price is 23.96 while SMMT 8-day exponential moving average is 25.04, which is a Sell signal.
  • The stock price of SMMT is 23.96 while Summit Therapeutics 20-day EMA is 24.73, which makes it a Sell.
  • Summit Therapeutics 50-day exponential moving average is 22.97 while SMMT share price is 23.96, making it a Buy technically.
  • SMMT stock price is 23.96 and Summit Therapeutics 200-day simple moving average is 18.44, creating a Buy signal.

Fundamental Analysis of Summit Therapeutics

Is Summit Therapeutics a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.10 per share, and a decrease next year of $0.11 per share.

Technical Analysis of Summit Therapeutics

Should I short Summit Therapeutics stock?

* Summit Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.